Women with a pelvic mass: Indicators of malignancy

European Journal of Gynaecological Oncology

Volumn 22, Issue 6, 2001, Pages 459-462

  Balbi, G C ^a   Musone, R ^a   Menditto, A ^a   Balbi, F ^a   Corcioni, C ^a   Calabria, G ^a   Maciariello, C ^a   Balbi, C ^a  

^a NONE   (Italy)

Author keywords

CA125; CA72 4; Doppler ultrasonography; Pelvic examination; Pelvic mass; Ultrasonography

Indexed keywords

CA 125 ANTIGEN; CA 72-4 ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; PELVIS CANCER; PHYSICAL EXAMINATION; PREDICTION; PROTEIN BLOOD LEVEL; TRANSVAGINAL ECHOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CA-125 ANTIGEN; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; PELVIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 0035715570     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. A monoclonal antibody immunoradiometric assay for an antigenic determinant (CA125) associated with uman epithelial ovarian carcinomas
2. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer
3. The CA125 tumor associated antigen: A review of the literature
4. CA125 in gynecological pathology-a review
5. A monoclonal antibody (B 72-3) defines pattern of distribution of a novel tumor-associated antigen in Human mammary cell population
6. Distribution of oncofetal antigen tumor associated glycoprotein-72 defined by monoclonal antibody B 72-3
7. A radioimmunoassay for the detection of a human tumor associated glycoprotein (TAG-72) using monoclonal antibody B 72-3
8. Low frequency and low level of elevation of serum CA72-4 in human carcinomas in comparison with established tumor markers
9. The concomitant determination of different serum tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: Relevance for differential diagnosis
10. Prospective multicenter study on the clinical utility of CA72-4 in postmenopausal patients with pelvic mass
11. Tumors in the lower pelvis as imaged by vaginal sonography
12. Evaluation of adenaxal masses with transvaginal colour ultrasound
13. Transvaginal color flow imaging: A possible new screening technique for ovarian cancer
14. Transvaginal color flow imaging in the diagnosis of ovarian cancer
15. Differentiating malignant from benign ovarian tumors with transvaginal colour flow imaging
16. Intratumoral peak systolic velocity as a new possible predictor for detection of adnexal malignancy
17. A comparation of intratumorai indices of blood flow velocity and impedance for the diagnosis of ovarian cancer
18. Blood flow in benign ovarian tumors and normal ovaries during the follicular phase
19. Limited contribution of Doppler velocimetry to the differential diagnosis of extrauterine pelvic tumors
20. Doppler ultrasound waveform indices: A/B ratio, pulsatility index and Pourcelot ratio
21. International histological classification of tumors
22. Diagnostic value of pelvic examination, ultrasound and serum CA125 in postmenopausal women presenting with a pelvic mass, an international multicenter study
23. Comparative evaluation of diagnostic methods in ovarian carcinoma with emphasis on CT and MRI
24. Comparation of serum CA125, clinical impression, and ultrasound in the preoperative evaluation of pelvic masses
25. Predictive value of CA125 for ovarian carcinoma in patients presenting with pelvic masses
26. Serum CA125 levels in preoperative evaluation of pelvic masses
27. Preoperative evaluation of serum CA125 levels in premenopausal and postmenopausal patients with pelvic masses: Discrimination of benign from malignant disease
28. Tumors in the lower pelvis as imaged by vaginal sonography
29. Tumor angiogenesis: Therapeutic implications
30. Isolation of a tumor factor responsible for angiogenesis
31. Association of ovarian malignancy with expression of plateled-derived endothelial cell growth factor